Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Riken Vitamin Co., Ltd. (4526)
Market Closed
10 Aug, 06:00
JPX
All
(1)
JP
(1)
JPX
Primary
¥
3,215.
00
+60
+1.9017%
¥
87.18B
Market Cap
-
P/E Ratio
110%
Div Yield
66,700
Volume
-
Eps
¥
3,155
Previous Close
Watching
Watch
Add Transaction
Day Range
3,155
3,235
Year Range
2,662
3,295
Want to track
4526
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Riken Vitamin Co., Ltd. (4526) Statistics
Valuation metrics
Market Cap
87.18B
Enterprise value
79.16B
Trailing P/E (ttm)
13.25
Forward P/E
9.84
PEG ratio
-0.57
Price/Sales (ttm)
0.96
Price/Book (mrq)
1.1
Enterprise Value/Revenue
0.82
Enterprise Value/EBITDA
6.56
Overview
Shares outstanding
29.57M
Float
21.43M
Shares short
-
% Held by insiders
0.27%
% Held by institutions
0.19%
Average volume (10 days)
67.03K
Average volume (90 days)
84.42K
Price summary
52-Week low
2,662
52-Week high
3,295
Beta
0.01
50-Day moving average
3,122.66
200-Day moving average
2,985.4
Dividends and splits
Forward annual dividend rate
110
Forward annual dividend yield
0.0398%
Trailing annual dividend rate
110
Trailing annual dividend yield
0.0349%
5-Year annual dividend yield
3.04%
Payout ratio
0.34
Dividend Date
1 Dec 2025
Ex-Dividend Date
29 Sep 2025
Last split factor
2:1
Last split Date
30 Mar 2020
Financials
Fiscal year
Fiscal year ends
31 Mar 2026
Most recent quarter (mrq)
30 Jun 2025
Profitability
Profit margin
0.07%
Operating margin
0.07%
Operational effectiveness
Return on assets
0.06%
Return on equity
0.09%
Income Statement
Revenue (ttm)
96.3B
Revenue per share (ttm)
3,318.63
Quarterly revenue growth (yoy)
0.05%
Gross profit (ttm)
29.77B
EBITDA
12.74B
Net income to common (ttm)
7.03B
Diluted EPS (ttm)
242.47
Quarterly earnings growth (yoy)
-0.69%
Balance Sheet
Total cash (mrq)
20.07B
Total cash per share (mrq)
691.64
Total debt (mrq)
7.14B
Total Debt/Equity (mrq)
0.09
Current ratio (mrq)
3.41%
Book value per share (mrq)
2,873.46
Cash Flow
Cash flow statement
5.96B
Levered free cash flow (LFCF)
904.5M